CJC-1295 & Ipamorelin Peptide 

Explore the science behind CJC-1295, Ipamorelin, and emerging growth hormone peptide research.

CJC-1295 and Ipamorelin are two investigational synthetic peptides being studied for their potential biological effects on natural growth hormone signaling, metabolic regulation, and cellular processes associated with tissue maintenance and recovery.

CJC-1295 is a growth hormone-releasing hormone (GHRH) analogue, while Ipamorelin is a growth hormone secretagogue that interacts with the ghrelin receptor. These compounds act through different biological pathways involved in growth hormone secretion.

Early laboratory and clinical research has explored these peptides individually in connection with:

• Growth Hormone & IGF-1 Research: Investigations into biological pathways involved in growth hormone secretion, insulin-like growth factor-1 (IGF-1), and endocrine signaling.

• Muscle & Body Composition Research: Studies exploring the relationship between growth hormone signaling, protein metabolism, lean tissue maintenance, and body composition.

• Metabolic Health Research: Investigations into hormonal pathways associated with energy metabolism, nutrient utilization, and metabolic regulation.

• Sleep & Recovery Research: Research examining relationships between growth hormone secretion, sleep physiology, and normal cellular recovery processes.

• Bone & Connective Tissue Research: Studies exploring the role of growth hormone and IGF-1 signaling in bone metabolism, connective tissue maintenance, and tissue remodeling.

• Healthy Aging Research: Investigations into age-related changes in growth hormone signaling and their relationship to normal physiological processes.

Important: These are investigational research areas, not established clinical benefits of CJC-1295 and Ipamorelin. Research on the individual compounds does not establish that their combined use improves muscle growth, fat loss, sleep, recovery, or longevity. Human research involving the specific combination remains extremely limited, and its safety and effectiveness have not been established.

Important Medical Information

CJC-1295 and Ipamorelin are not approved by the U.S. Food and Drug Administration (FDA) for human use or for the diagnosis, treatment, cure, or prevention of any disease or injury.

Their safety, efficacy, optimal dosage, long-term effects, and potential risks when used in combination have not been established. FDA has identified potential safety concerns associated with these compounds, including adverse cardiovascular reactions reported with CJC-1295 and potential immunogenicity risks associated with peptide impurities.

Information on this page is provided for educational purposes only and does not constitute medical advice or a recommendation to use CJC-1295 or Ipamorelin.  Product comes with Certificate of Analysis for purity and potency. Made in the USA.

• Pricing: $250 per month - Listed program pricing; availability and eligibility are subject to medical and regulatory review.

• Questions? Contact Renew Aesthetics & IV Hydration Bar at 208-930-6823.